Status:
COMPLETED
Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological Suppression
Lead Sponsor:
Boehringer Ingelheim
Conditions:
HIV Infections
Eligibility:
All Genders
Brief Summary
Observational study to evaluate therapeutic switch to a NNRTI-based regimen on quality of life of HIV-positive patients
Eligibility Criteria
Inclusion
- NNRTI-naive patients with positive HIV serology, treated with at least triple combination therapy, with a viral load \< 500 copies/ml, in whom a new treatment comprising an NNRTI is initiated for a reason other than inefficacy of treatment will be included
- Patients must read and write French
Exclusion
- Patients in whom a new treatment is initiated because of treatment failure
- new treatment does not comprise an NNRTI
Key Trial Info
Start Date :
June 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
283 Patients enrolled
Trial Details
Trial ID
NCT02191202
Start Date
June 1 2004
Last Update
July 16 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.